img

Global Rabies Immune Globulin (Equine) Market Research Report 2024


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Rabies Immune Globulin (Equine) Market Research Report 2024

According to Mr Accuracy reports’s new survey, global Rabies Immune Globulin (Equine) market is projected to reach US$ 1526.7 million in 2034, increasing from US$ 1200 million in 2022, with the CAGR of 3.5% during the period of 2024 to 2034. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Rabies Immune Globulin (Equine) market research.
Rabies Immune Globulin (Equine) is a medication used to prevent rabies infection in people who have been exposed to the virus. It is made from the blood of horses that have been immunized against rabies.

The development of Rabies Immune Globulin (Equine) involved the isolation and purification of antibodies from the blood of immunized horses. The process includes collecting blood from the horses, separating the plasma from the red blood cells, and purifying the antibodies using various techniques.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Rabies Immune Globulin (Equine) market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


Grifols
Serum China
Premium Serums
Intas
Aventis Pasteur India
Cadila Pharmaceuticals
Zydus Takeda Healthcare
Bharat Serums And Vaccines
GlaxoSmithKline GmbH
VINS Bioproducts
CSL Behring
Segment by Type
1500IU
1000IU
400IU
Others

Segment by Application


Clinic
Hospital

Consumption by Region


North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Rabies Immune Globulin (Equine) report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source

Table of Content

1 Rabies Immune Globulin (Equine) Market Overview
1.1 Product Overview and Scope of Rabies Immune Globulin (Equine)
1.2 Rabies Immune Globulin (Equine) Segment by Type
1.2.1 Global Rabies Immune Globulin (Equine) Market Value Comparison by Type (2024-2034)
1.2.2 1500IU
1.2.3 1000IU
1.2.4 400IU
1.2.5 Others
1.3 Rabies Immune Globulin (Equine) Segment by Application
1.3.1 Global Rabies Immune Globulin (Equine) Market Value by Application: (2024-2034)
1.3.2 Clinic
1.3.3 Hospital
1.4 Global Rabies Immune Globulin (Equine) Market Size Estimates and Forecasts
1.4.1 Global Rabies Immune Globulin (Equine) Revenue 2024-2034
1.4.2 Global Rabies Immune Globulin (Equine) Sales 2024-2034
1.4.3 Global Rabies Immune Globulin (Equine) Market Average Price (2024-2034)
1.5 Assumptions and Limitations
2 Rabies Immune Globulin (Equine) Market Competition by Manufacturers
2.1 Global Rabies Immune Globulin (Equine) Sales Market Share by Manufacturers (2024-2024)
2.2 Global Rabies Immune Globulin (Equine) Revenue Market Share by Manufacturers (2024-2024)
2.3 Global Rabies Immune Globulin (Equine) Average Price by Manufacturers (2024-2024)
2.4 Global Rabies Immune Globulin (Equine) Industry Ranking 2021 VS 2022 VS 2024
2.5 Global Key Manufacturers of Rabies Immune Globulin (Equine), Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Rabies Immune Globulin (Equine), Product Type & Application
2.7 Rabies Immune Globulin (Equine) Market Competitive Situation and Trends
2.7.1 Rabies Immune Globulin (Equine) Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Rabies Immune Globulin (Equine) Players Market Share by Revenue
2.7.3 Global Rabies Immune Globulin (Equine) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Rabies Immune Globulin (Equine) Retrospective Market Scenario by Region
3.1 Global Rabies Immune Globulin (Equine) Market Size by Region: 2024 Versus 2022 Versus 2034
3.2 Global Rabies Immune Globulin (Equine) Global Rabies Immune Globulin (Equine) Sales by Region: 2024-2034
3.2.1 Global Rabies Immune Globulin (Equine) Sales by Region: 2024-2024
3.2.2 Global Rabies Immune Globulin (Equine) Sales by Region: 2024-2034
3.3 Global Rabies Immune Globulin (Equine) Global Rabies Immune Globulin (Equine) Revenue by Region: 2024-2034
3.3.1 Global Rabies Immune Globulin (Equine) Revenue by Region: 2024-2024
3.3.2 Global Rabies Immune Globulin (Equine) Revenue by Region: 2024-2034
3.4 North America Rabies Immune Globulin (Equine) Market Facts & Figures by Country
3.4.1 North America Rabies Immune Globulin (Equine) Market Size by Country: 2024 VS 2022 VS 2034
3.4.2 North America Rabies Immune Globulin (Equine) Sales by Country (2024-2034)
3.4.3 North America Rabies Immune Globulin (Equine) Revenue by Country (2024-2034)
3.4.4 United States
3.4.5 Canada
3.5 Europe Rabies Immune Globulin (Equine) Market Facts & Figures by Country
3.5.1 Europe Rabies Immune Globulin (Equine) Market Size by Country: 2024 VS 2022 VS 2034
3.5.2 Europe Rabies Immune Globulin (Equine) Sales by Country (2024-2034)
3.5.3 Europe Rabies Immune Globulin (Equine) Revenue by Country (2024-2034)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Rabies Immune Globulin (Equine) Market Facts & Figures by Country
3.6.1 Asia Pacific Rabies Immune Globulin (Equine) Market Size by Country: 2024 VS 2022 VS 2034
3.6.2 Asia Pacific Rabies Immune Globulin (Equine) Sales by Country (2024-2034)
3.6.3 Asia Pacific Rabies Immune Globulin (Equine) Revenue by Country (2024-2034)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Rabies Immune Globulin (Equine) Market Facts & Figures by Country
3.7.1 Latin America Rabies Immune Globulin (Equine) Market Size by Country: 2024 VS 2022 VS 2034
3.7.2 Latin America Rabies Immune Globulin (Equine) Sales by Country (2024-2034)
3.7.3 Latin America Rabies Immune Globulin (Equine) Revenue by Country (2024-2034)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Rabies Immune Globulin (Equine) Market Facts & Figures by Country
3.8.1 Middle East and Africa Rabies Immune Globulin (Equine) Market Size by Country: 2024 VS 2022 VS 2034
3.8.2 Middle East and Africa Rabies Immune Globulin (Equine) Sales by Country (2024-2034)
3.8.3 Middle East and Africa Rabies Immune Globulin (Equine) Revenue by Country (2024-2034)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Rabies Immune Globulin (Equine) Sales by Type (2024-2034)
4.1.1 Global Rabies Immune Globulin (Equine) Sales by Type (2024-2024)
4.1.2 Global Rabies Immune Globulin (Equine) Sales by Type (2024-2034)
4.1.3 Global Rabies Immune Globulin (Equine) Sales Market Share by Type (2024-2034)
4.2 Global Rabies Immune Globulin (Equine) Revenue by Type (2024-2034)
4.2.1 Global Rabies Immune Globulin (Equine) Revenue by Type (2024-2024)
4.2.2 Global Rabies Immune Globulin (Equine) Revenue by Type (2024-2034)
4.2.3 Global Rabies Immune Globulin (Equine) Revenue Market Share by Type (2024-2034)
4.3 Global Rabies Immune Globulin (Equine) Price by Type (2024-2034)
5 Segment by Application
5.1 Global Rabies Immune Globulin (Equine) Sales by Application (2024-2034)
5.1.1 Global Rabies Immune Globulin (Equine) Sales by Application (2024-2024)
5.1.2 Global Rabies Immune Globulin (Equine) Sales by Application (2024-2034)
5.1.3 Global Rabies Immune Globulin (Equine) Sales Market Share by Application (2024-2034)
5.2 Global Rabies Immune Globulin (Equine) Revenue by Application (2024-2034)
5.2.1 Global Rabies Immune Globulin (Equine) Revenue by Application (2024-2024)
5.2.2 Global Rabies Immune Globulin (Equine) Revenue by Application (2024-2034)
5.2.3 Global Rabies Immune Globulin (Equine) Revenue Market Share by Application (2024-2034)
5.3 Global Rabies Immune Globulin (Equine) Price by Application (2024-2034)
6 Key Companies Profiled
6.1 Grifols
6.1.1 Grifols Corporation Information
6.1.2 Grifols Description and Business Overview
6.1.3 Grifols Rabies Immune Globulin (Equine) Sales, Revenue and Gross Margin (2024-2024)
6.1.4 Grifols Rabies Immune Globulin (Equine) Product Portfolio
6.1.5 Grifols Recent Developments/Updates
6.2 Serum China
6.2.1 Serum China Corporation Information
6.2.2 Serum China Description and Business Overview
6.2.3 Serum China Rabies Immune Globulin (Equine) Sales, Revenue and Gross Margin (2024-2024)
6.2.4 Serum China Rabies Immune Globulin (Equine) Product Portfolio
6.2.5 Serum China Recent Developments/Updates
6.3 Premium Serums
6.3.1 Premium Serums Corporation Information
6.3.2 Premium Serums Description and Business Overview
6.3.3 Premium Serums Rabies Immune Globulin (Equine) Sales, Revenue and Gross Margin (2024-2024)
6.3.4 Premium Serums Rabies Immune Globulin (Equine) Product Portfolio
6.3.5 Premium Serums Recent Developments/Updates
6.4 Intas
6.4.1 Intas Corporation Information
6.4.2 Intas Description and Business Overview
6.4.3 Intas Rabies Immune Globulin (Equine) Sales, Revenue and Gross Margin (2024-2024)
6.4.4 Intas Rabies Immune Globulin (Equine) Product Portfolio
6.4.5 Intas Recent Developments/Updates
6.5 Aventis Pasteur India
6.5.1 Aventis Pasteur India Corporation Information
6.5.2 Aventis Pasteur India Description and Business Overview
6.5.3 Aventis Pasteur India Rabies Immune Globulin (Equine) Sales, Revenue and Gross Margin (2024-2024)
6.5.4 Aventis Pasteur India Rabies Immune Globulin (Equine) Product Portfolio
6.5.5 Aventis Pasteur India Recent Developments/Updates
6.6 Cadila Pharmaceuticals
6.6.1 Cadila Pharmaceuticals Corporation Information
6.6.2 Cadila Pharmaceuticals Description and Business Overview
6.6.3 Cadila Pharmaceuticals Rabies Immune Globulin (Equine) Sales, Revenue and Gross Margin (2024-2024)
6.6.4 Cadila Pharmaceuticals Rabies Immune Globulin (Equine) Product Portfolio
6.6.5 Cadila Pharmaceuticals Recent Developments/Updates
6.7 Zydus Takeda Healthcare
6.6.1 Zydus Takeda Healthcare Corporation Information
6.6.2 Zydus Takeda Healthcare Description and Business Overview
6.6.3 Zydus Takeda Healthcare Rabies Immune Globulin (Equine) Sales, Revenue and Gross Margin (2024-2024)
6.4.4 Zydus Takeda Healthcare Rabies Immune Globulin (Equine) Product Portfolio
6.7.5 Zydus Takeda Healthcare Recent Developments/Updates
6.8 Bharat Serums And Vaccines
6.8.1 Bharat Serums And Vaccines Corporation Information
6.8.2 Bharat Serums And Vaccines Description and Business Overview
6.8.3 Bharat Serums And Vaccines Rabies Immune Globulin (Equine) Sales, Revenue and Gross Margin (2024-2024)
6.8.4 Bharat Serums And Vaccines Rabies Immune Globulin (Equine) Product Portfolio
6.8.5 Bharat Serums And Vaccines Recent Developments/Updates
6.9 GlaxoSmithKline GmbH
6.9.1 GlaxoSmithKline GmbH Corporation Information
6.9.2 GlaxoSmithKline GmbH Description and Business Overview
6.9.3 GlaxoSmithKline GmbH Rabies Immune Globulin (Equine) Sales, Revenue and Gross Margin (2024-2024)
6.9.4 GlaxoSmithKline GmbH Rabies Immune Globulin (Equine) Product Portfolio
6.9.5 GlaxoSmithKline GmbH Recent Developments/Updates
6.10 VINS Bioproducts
6.10.1 VINS Bioproducts Corporation Information
6.10.2 VINS Bioproducts Description and Business Overview
6.10.3 VINS Bioproducts Rabies Immune Globulin (Equine) Sales, Revenue and Gross Margin (2024-2024)
6.10.4 VINS Bioproducts Rabies Immune Globulin (Equine) Product Portfolio
6.10.5 VINS Bioproducts Recent Developments/Updates
6.11 CSL Behring
6.11.1 CSL Behring Corporation Information
6.11.2 CSL Behring Rabies Immune Globulin (Equine) Description and Business Overview
6.11.3 CSL Behring Rabies Immune Globulin (Equine) Sales, Revenue and Gross Margin (2024-2024)
6.11.4 CSL Behring Rabies Immune Globulin (Equine) Product Portfolio
6.11.5 CSL Behring Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Rabies Immune Globulin (Equine) Industry Chain Analysis
7.2 Rabies Immune Globulin (Equine) Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Rabies Immune Globulin (Equine) Production Mode & Process
7.4 Rabies Immune Globulin (Equine) Sales and Marketing
7.4.1 Rabies Immune Globulin (Equine) Sales Channels
7.4.2 Rabies Immune Globulin (Equine) Distributors
7.5 Rabies Immune Globulin (Equine) Customers
8 Rabies Immune Globulin (Equine) Market Dynamics
8.1 Rabies Immune Globulin (Equine) Industry Trends
8.2 Rabies Immune Globulin (Equine) Market Drivers
8.3 Rabies Immune Globulin (Equine) Market Challenges
8.4 Rabies Immune Globulin (Equine) Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Rabies Immune Globulin (Equine) Market Value Comparison by Type (2024-2034) & (US$ Million)
Table 2. Global Rabies Immune Globulin (Equine) Market Value Comparison by Application (2024-2034) & (US$ Million)
Table 3. Global Rabies Immune Globulin (Equine) Market Competitive Situation by Manufacturers in 2022
Table 4. Global Rabies Immune Globulin (Equine) Sales (K Units) of Key Manufacturers (2024-2024)
Table 5. Global Rabies Immune Globulin (Equine) Sales Market Share by Manufacturers (2024-2024)
Table 6. Global Rabies Immune Globulin (Equine) Revenue (US$ Million) by Manufacturers (2024-2024)
Table 7. Global Rabies Immune Globulin (Equine) Revenue Share by Manufacturers (2024-2024)
Table 8. Global Market Rabies Immune Globulin (Equine) Average Price (US$/Unit) of Key Manufacturers (2024-2024)
Table 9. Global Key Players of Rabies Immune Globulin (Equine), Industry Ranking, 2021 VS 2022 VS 2024
Table 10. Global Key Manufacturers of Rabies Immune Globulin (Equine), Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Rabies Immune Globulin (Equine), Product Type & Application
Table 12. Global Key Manufacturers of Rabies Immune Globulin (Equine), Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Rabies Immune Globulin (Equine) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Rabies Immune Globulin (Equine) as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Rabies Immune Globulin (Equine) Market Size by Region (US$ Million): 2024 VS 2022 VS 2034
Table 17. Global Rabies Immune Globulin (Equine) Sales by Region (2024-2024) & (K Units)
Table 18. Global Rabies Immune Globulin (Equine) Sales Market Share by Region (2024-2024)
Table 19. Global Rabies Immune Globulin (Equine) Sales by Region (2024-2034) & (K Units)
Table 20. Global Rabies Immune Globulin (Equine) Sales Market Share by Region (2024-2034)
Table 21. Global Rabies Immune Globulin (Equine) Revenue by Region (2024-2024) & (US$ Million)
Table 22. Global Rabies Immune Globulin (Equine) Revenue Market Share by Region (2024-2024)
Table 23. Global Rabies Immune Globulin (Equine) Revenue by Region (2024-2034) & (US$ Million)
Table 24. Global Rabies Immune Globulin (Equine) Revenue Market Share by Region (2024-2034)
Table 25. North America Rabies Immune Globulin (Equine) Revenue by Country: 2024 VS 2022 VS 2034 (US$ Million)
Table 26. North America Rabies Immune Globulin (Equine) Sales by Country (2024-2024) & (K Units)
Table 27. North America Rabies Immune Globulin (Equine) Sales by Country (2024-2034) & (K Units)
Table 28. North America Rabies Immune Globulin (Equine) Revenue by Country (2024-2024) & (US$ Million)
Table 29. North America Rabies Immune Globulin (Equine) Revenue by Country (2024-2034) & (US$ Million)
Table 30. Europe Rabies Immune Globulin (Equine) Revenue by Country: 2024 VS 2022 VS 2034 (US$ Million)
Table 31. Europe Rabies Immune Globulin (Equine) Sales by Country (2024-2024) & (K Units)
Table 32. Europe Rabies Immune Globulin (Equine) Sales by Country (2024-2034) & (K Units)
Table 33. Europe Rabies Immune Globulin (Equine) Revenue by Country (2024-2024) & (US$ Million)
Table 34. Europe Rabies Immune Globulin (Equine) Revenue by Country (2024-2034) & (US$ Million)
Table 35. Asia Pacific Rabies Immune Globulin (Equine) Revenue by Region: 2024 VS 2022 VS 2034 (US$ Million)
Table 36. Asia Pacific Rabies Immune Globulin (Equine) Sales by Region (2024-2024) & (K Units)
Table 37. Asia Pacific Rabies Immune Globulin (Equine) Sales by Region (2024-2034) & (K Units)
Table 38. Asia Pacific Rabies Immune Globulin (Equine) Revenue by Region (2024-2024) & (US$ Million)
Table 39. Asia Pacific Rabies Immune Globulin (Equine) Revenue by Region (2024-2034) & (US$ Million)
Table 40. Latin America Rabies Immune Globulin (Equine) Revenue by Country: 2024 VS 2022 VS 2034 (US$ Million)
Table 41. Latin America Rabies Immune Globulin (Equine) Sales by Country (2024-2024) & (K Units)
Table 42. Latin America Rabies Immune Globulin (Equine) Sales by Country (2024-2034) & (K Units)
Table 43. Latin America Rabies Immune Globulin (Equine) Revenue by Country (2024-2024) & (US$ Million)
Table 44. Latin America Rabies Immune Globulin (Equine) Revenue by Country (2024-2034) & (US$ Million)
Table 45. Middle East & Africa Rabies Immune Globulin (Equine) Revenue by Country: 2024 VS 2022 VS 2034 (US$ Million)
Table 46. Middle East & Africa Rabies Immune Globulin (Equine) Sales by Country (2024-2024) & (K Units)
Table 47. Middle East & Africa Rabies Immune Globulin (Equine) Sales by Country (2024-2034) & (K Units)
Table 48. Middle East & Africa Rabies Immune Globulin (Equine) Revenue by Country (2024-2024) & (US$ Million)
Table 49. Middle East & Africa Rabies Immune Globulin (Equine) Revenue by Country (2024-2034) & (US$ Million)
Table 50. Global Rabies Immune Globulin (Equine) Sales (K Units) by Type (2024-2024)
Table 51. Global Rabies Immune Globulin (Equine) Sales (K Units) by Type (2024-2034)
Table 52. Global Rabies Immune Globulin (Equine) Sales Market Share by Type (2024-2024)
Table 53. Global Rabies Immune Globulin (Equine) Sales Market Share by Type (2024-2034)
Table 54. Global Rabies Immune Globulin (Equine) Revenue (US$ Million) by Type (2024-2024)
Table 55. Global Rabies Immune Globulin (Equine) Revenue (US$ Million) by Type (2024-2034)
Table 56. Global Rabies Immune Globulin (Equine) Revenue Market Share by Type (2024-2024)
Table 57. Global Rabies Immune Globulin (Equine) Revenue Market Share by Type (2024-2034)
Table 58. Global Rabies Immune Globulin (Equine) Price (US$/Unit) by Type (2024-2024)
Table 59. Global Rabies Immune Globulin (Equine) Price (US$/Unit) by Type (2024-2034)
Table 60. Global Rabies Immune Globulin (Equine) Sales (K Units) by Application (2024-2024)
Table 61. Global Rabies Immune Globulin (Equine) Sales (K Units) by Application (2024-2034)
Table 62. Global Rabies Immune Globulin (Equine) Sales Market Share by Application (2024-2024)
Table 63. Global Rabies Immune Globulin (Equine) Sales Market Share by Application (2024-2034)
Table 64. Global Rabies Immune Globulin (Equine) Revenue (US$ Million) by Application (2024-2024)
Table 65. Global Rabies Immune Globulin (Equine) Revenue (US$ Million) by Application (2024-2034)
Table 66. Global Rabies Immune Globulin (Equine) Revenue Market Share by Application (2024-2024)
Table 67. Global Rabies Immune Globulin (Equine) Revenue Market Share by Application (2024-2034)
Table 68. Global Rabies Immune Globulin (Equine) Price (US$/Unit) by Application (2024-2024)
Table 69. Global Rabies Immune Globulin (Equine) Price (US$/Unit) by Application (2024-2034)
Table 70. Grifols Corporation Information
Table 71. Grifols Description and Business Overview
Table 72. Grifols Rabies Immune Globulin (Equine) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 73. Grifols Rabies Immune Globulin (Equine) Product
Table 74. Grifols Recent Developments/Updates
Table 75. Serum China Corporation Information
Table 76. Serum China Description and Business Overview
Table 77. Serum China Rabies Immune Globulin (Equine) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 78. Serum China Rabies Immune Globulin (Equine) Product
Table 79. Serum China Recent Developments/Updates
Table 80. Premium Serums Corporation Information
Table 81. Premium Serums Description and Business Overview
Table 82. Premium Serums Rabies Immune Globulin (Equine) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 83. Premium Serums Rabies Immune Globulin (Equine) Product
Table 84. Premium Serums Recent Developments/Updates
Table 85. Intas Corporation Information
Table 86. Intas Description and Business Overview
Table 87. Intas Rabies Immune Globulin (Equine) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 88. Intas Rabies Immune Globulin (Equine) Product
Table 89. Intas Recent Developments/Updates
Table 90. Aventis Pasteur India Corporation Information
Table 91. Aventis Pasteur India Description and Business Overview
Table 92. Aventis Pasteur India Rabies Immune Globulin (Equine) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 93. Aventis Pasteur India Rabies Immune Globulin (Equine) Product
Table 94. Aventis Pasteur India Recent Developments/Updates
Table 95. Cadila Pharmaceuticals Corporation Information
Table 96. Cadila Pharmaceuticals Description and Business Overview
Table 97. Cadila Pharmaceuticals Rabies Immune Globulin (Equine) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 98. Cadila Pharmaceuticals Rabies Immune Globulin (Equine) Product
Table 99. Cadila Pharmaceuticals Recent Developments/Updates
Table 100. Zydus Takeda Healthcare Corporation Information
Table 101. Zydus Takeda Healthcare Description and Business Overview
Table 102. Zydus Takeda Healthcare Rabies Immune Globulin (Equine) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 103. Zydus Takeda Healthcare Rabies Immune Globulin (Equine) Product
Table 104. Zydus Takeda Healthcare Recent Developments/Updates
Table 105. Bharat Serums And Vaccines Corporation Information
Table 106. Bharat Serums And Vaccines Description and Business Overview
Table 107. Bharat Serums And Vaccines Rabies Immune Globulin (Equine) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 108. Bharat Serums And Vaccines Rabies Immune Globulin (Equine) Product
Table 109. Bharat Serums And Vaccines Recent Developments/Updates
Table 110. GlaxoSmithKline GmbH Corporation Information
Table 111. GlaxoSmithKline GmbH Description and Business Overview
Table 112. GlaxoSmithKline GmbH Rabies Immune Globulin (Equine) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 113. GlaxoSmithKline GmbH Rabies Immune Globulin (Equine) Product
Table 114. GlaxoSmithKline GmbH Recent Developments/Updates
Table 115. VINS Bioproducts Corporation Information
Table 116. VINS Bioproducts Description and Business Overview
Table 117. VINS Bioproducts Rabies Immune Globulin (Equine) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 118. VINS Bioproducts Rabies Immune Globulin (Equine) Product
Table 119. VINS Bioproducts Recent Developments/Updates
Table 120. CSL Behring Corporation Information
Table 121. CSL Behring Description and Business Overview
Table 122. CSL Behring Rabies Immune Globulin (Equine) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 123. CSL Behring Rabies Immune Globulin (Equine) Product
Table 124. CSL Behring Recent Developments/Updates
Table 125. Key Raw Materials Lists
Table 126. Raw Materials Key Suppliers Lists
Table 127. Rabies Immune Globulin (Equine) Distributors List
Table 128. Rabies Immune Globulin (Equine) Customers List
Table 129. Rabies Immune Globulin (Equine) Market Trends
Table 130. Rabies Immune Globulin (Equine) Market Drivers
Table 131. Rabies Immune Globulin (Equine) Market Challenges
Table 132. Rabies Immune Globulin (Equine) Market Restraints
Table 133. Research Programs/Design for This Report
Table 134. Key Data Information from Secondary Sources
Table 135. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Rabies Immune Globulin (Equine)
Figure 2. Global Rabies Immune Globulin (Equine) Market Value Comparison by Type (2024-2034) & (US$ Million)
Figure 3. Global Rabies Immune Globulin (Equine) Market Share by Type in 2022 & 2034
Figure 4. 1500IU Product Picture
Figure 5. 1000IU Product Picture
Figure 6. 400IU Product Picture
Figure 7. Others Product Picture
Figure 8. Global Rabies Immune Globulin (Equine) Market Value Comparison by Application (2024-2034) & (US$ Million)
Figure 9. Global Rabies Immune Globulin (Equine) Market Share by Application in 2022 & 2034
Figure 10. Clinic
Figure 11. Hospital
Figure 12. Global Rabies Immune Globulin (Equine) Revenue, (US$ Million), 2024 VS 2022 VS 2034
Figure 13. Global Rabies Immune Globulin (Equine) Market Size (2024-2034) & (US$ Million)
Figure 14. Global Rabies Immune Globulin (Equine) Sales (2024-2034) & (K Units)
Figure 15. Global Rabies Immune Globulin (Equine) Average Price (US$/Unit) & (2024-2034)
Figure 16. Rabies Immune Globulin (Equine) Report Years Considered
Figure 17. Rabies Immune Globulin (Equine) Sales Share by Manufacturers in 2022
Figure 18. Global Rabies Immune Globulin (Equine) Revenue Share by Manufacturers in 2022
Figure 19. The Global 5 and 10 Largest Rabies Immune Globulin (Equine) Players: Market Share by Revenue in 2022
Figure 20. Rabies Immune Globulin (Equine) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024 VS 2022
Figure 21. Global Rabies Immune Globulin (Equine) Market Size by Region (US$ Million): 2024 VS 2022 VS 2034
Figure 22. North America Rabies Immune Globulin (Equine) Sales Market Share by Country (2024-2034)
Figure 23. North America Rabies Immune Globulin (Equine) Revenue Market Share by Country (2024-2034)
Figure 24. United States Rabies Immune Globulin (Equine) Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 25. Canada Rabies Immune Globulin (Equine) Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 26. Europe Rabies Immune Globulin (Equine) Sales Market Share by Country (2024-2034)
Figure 27. Europe Rabies Immune Globulin (Equine) Revenue Market Share by Country (2024-2034)
Figure 28. Germany Rabies Immune Globulin (Equine) Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 29. France Rabies Immune Globulin (Equine) Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 30. U.K. Rabies Immune Globulin (Equine) Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 31. Italy Rabies Immune Globulin (Equine) Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 32. Russia Rabies Immune Globulin (Equine) Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 33. Asia Pacific Rabies Immune Globulin (Equine) Sales Market Share by Region (2024-2034)
Figure 34. Asia Pacific Rabies Immune Globulin (Equine) Revenue Market Share by Region (2024-2034)
Figure 35. China Rabies Immune Globulin (Equine) Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 36. Japan Rabies Immune Globulin (Equine) Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 37. South Korea Rabies Immune Globulin (Equine) Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 38. India Rabies Immune Globulin (Equine) Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 39. Australia Rabies Immune Globulin (Equine) Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 40. China Taiwan Rabies Immune Globulin (Equine) Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 41. Southeast Asia Rabies Immune Globulin (Equine) Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 42. Latin America Rabies Immune Globulin (Equine) Sales Market Share by Country (2024-2034)
Figure 43. Latin America Rabies Immune Globulin (Equine) Revenue Market Share by Country (2024-2034)
Figure 44. Mexico Rabies Immune Globulin (Equine) Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 45. Brazil Rabies Immune Globulin (Equine) Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 46. Argentina Rabies Immune Globulin (Equine) Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 47. Colombia Rabies Immune Globulin (Equine) Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 48. Middle East & Africa Rabies Immune Globulin (Equine) Sales Market Share by Country (2024-2034)
Figure 49. Middle East & Africa Rabies Immune Globulin (Equine) Revenue Market Share by Country (2024-2034)
Figure 50. Turkey Rabies Immune Globulin (Equine) Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 51. Saudi Arabia Rabies Immune Globulin (Equine) Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 52. UAE Rabies Immune Globulin (Equine) Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 53. Global Sales Market Share of Rabies Immune Globulin (Equine) by Type (2024-2034)
Figure 54. Global Revenue Market Share of Rabies Immune Globulin (Equine) by Type (2024-2034)
Figure 55. Global Rabies Immune Globulin (Equine) Price (US$/Unit) by Type (2024-2034)
Figure 56. Global Sales Market Share of Rabies Immune Globulin (Equine) by Application (2024-2034)
Figure 57. Global Revenue Market Share of Rabies Immune Globulin (Equine) by Application (2024-2034)
Figure 58. Global Rabies Immune Globulin (Equine) Price (US$/Unit) by Application (2024-2034)
Figure 59. Rabies Immune Globulin (Equine) Value Chain
Figure 60. Rabies Immune Globulin (Equine) Production Process
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Distributors Profiles
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed